May 1, 2020 / 8:59 PM / a month ago

BRIEF-Quotient Limited Announces CE Mark For Its Sars-Cov-2 (Covid-19) Antibody Microarray

May 1 (Reuters) - Quotient Ltd:

* QUOTIENT LIMITED ANNOUNCES CE MARK FOR ITS SARS-COV-2 (COVID-19) ANTIBODY MICROARRAY

* QUOTIENT LTD - MOSAIQ COVID-19 ANTIBODY MICROARRAY IS DESIGNED AS A SEROLOGICAL DISEASE SCREEN SPECIFIC TO COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below